$VCYT
VERACYTE, INC. Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000138410121000082 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$36.70M	$31.12M
YoY Change	17.93%	5.39%
Cost Of Revenue	$12.40M	$12.24M
YoY Change	1.31%	43.78%
Gross Profit	$24.30M	$18.88M
YoY Change	28.71%	-10.16%
Gross Profit Margin	66.21%	60.66%
Selling, General & Admin	$62.58M	$25.40M
YoY Change	146.4%	31.04%
% of Gross Profit	257.52%	134.52%
Research & Development	$5.336M	$4.407M
YoY Change	21.08%	28.3%
% of Gross Profit	21.96%	23.34%
Depreciation & Amortization	$2.550M	$1.972M
YoY Change	29.31%	108.68%
% of Gross Profit	10.49%	10.44%
Operating Expenses	$67.91M	$29.80M
YoY Change	127.87%	30.63%
Operating Profit	-$45.42M	-$12.20M
YoY Change	272.25%	490.23%
Interest Expense	$53.00K	$55.00K
YoY Change	-3.64%	-81.85%
% of Operating Profit
Other Income/Expense, Net	-$248.0K	$539.0K
YoY Change	-146.01%	18.98%
Pretax Income	-$45.66M	-$11.72M
YoY Change	289.75%	510.21%
Income Tax	-$3.800M	$0.00
% Of Pretax Income
Net Earnings	-$41.87M	-$11.72M
YoY Change	257.36%	511.16%
Net Earnings / Revenue	-114.07%	-37.65%
Basic Earnings Per Share	-$0.66
Diluted Earnings Per Share	-$0.66	-$235.4K
COMMON SHARES
Basic Shares Outstanding	63.33M shares	49.74M shares
Diluted Shares Outstanding	63.33M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$324.1M	$153.1M
YoY Change	111.69%	125.81%
Cash & Equivalents	$324.1M	$153.1M
Short-Term Investments
Other Short-Term Assets	$3.800M	$3.000M
YoY Change	26.67%	25.0%
Inventory	$6.308M	$6.094M
Prepaid Expenses
Receivables	$27.88M	$19.09M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$362.1M	$181.4M
YoY Change	99.65%	100.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.56M	$8.788M
YoY Change	20.19%	8.31%
Goodwill	$474.8M	$2.725M
YoY Change	17325.25%	157.81%
Intangibles	$159.4M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.286M	$1.302M
YoY Change	75.58%	24.12%
Total Long-Term Assets	$663.0M	$85.74M
YoY Change	673.34%	160.44%
TOTAL ASSETS
Total Short-Term Assets	$362.1M	$181.4M
Total Long-Term Assets	$663.0M	$85.74M
Total Assets	$1.025B	$267.1M
YoY Change	283.8%	116.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.137M	$7.665M
YoY Change	-6.89%	88.61%
Accrued Expenses	$16.25M	$10.08M
YoY Change	61.27%	14.69%
Deferred Revenue	$454.0K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$32.71M	$19.19M
YoY Change	70.41%	33.95%
LONG-TERM LIABILITIES
Long-Term Debt	$863.0K	$748.0K
YoY Change	15.37%	-94.18%
Other Long-Term Liabilities	$16.60M	$16.70M
YoY Change	-0.6%	32.54%
Total Long-Term Liabilities	$863.0K	$748.0K
YoY Change	15.37%	-94.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.71M	$19.19M
Total Long-Term Liabilities	$863.0K	$748.0K
Total Liabilities	$50.91M	$36.68M
YoY Change	38.79%	-7.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$323.5M	-$258.4M
YoY Change	25.18%	9.49%
Common Stock	$1.298B	$488.8M
YoY Change	165.47%	52.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$974.2M	$230.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.025B	$267.1M
YoY Change	283.8%	116.21%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$41.87M	-$11.72M
YoY Change	257.36%	511.16%
Depreciation, Depletion And Amortization	$2.550M	$1.972M
YoY Change	29.31%	108.68%
Cash From Operating Activities	-$40.56M	-$5.301M
YoY Change	665.16%	424.33%
INVESTING ACTIVITIES
Capital Expenditures	$1.196M	$665.0K
YoY Change	79.85%	-13.07%
Acquisitions	$574.4M	$0.00
YoY Change
Other Investing Activities	-$574.4M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$575.6M	-$665.0K
YoY Change	86457.44%	-11.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00	$0.00
YoY Change		-100.0%
Cash From Financing Activities	$591.0M	-$219.0K
YoY Change	-269968.49%	-97.39%
NET CHANGE
Cash From Operating Activities	-$40.56M	-$5.301M
Cash From Investing Activities	-$575.6M	-$665.0K
Cash From Financing Activities	$591.0M	-$219.0K
Net Change In Cash	-$25.16M	-$6.185M
YoY Change	306.73%	-39.09%
FREE CASH FLOW
Cash From Operating Activities	-$40.56M	-$5.301M
Capital Expenditures	$1.196M	$665.0K
Free Cash Flow	-$41.76M	-$5.966M
YoY Change	599.92%	235.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3800000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-36156
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5455398
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6000 Shoreline Court
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	South San Francisco
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94080
CY2021Q1	dei	City Area Code CityAreaCode	(650)
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	243-6300
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, par value, $0.001 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	VCYT
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	67248259	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	324062000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	349364000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27877000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18461000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	6308000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	4657000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3845000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3197000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	362092000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	375679000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10562000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8990000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15186000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7843000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	159423000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	59924000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	474838000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2725000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2286000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1399000	USD
CY2021Q1	us-gaap	Assets Assets	1025136000	USD
CY2020Q4	us-gaap	Assets Assets	457163000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7137000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3116000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16254000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11705000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	454000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	371000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5986000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2878000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1589000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32709000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16781000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	863000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	810000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	747000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	829000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	750000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1800000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	7594000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14036000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9917000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	50905000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	35931000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67236162	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67236162	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58200526	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58200526	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	67000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	58000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1297626000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	702768000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-323462000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-281594000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	974231000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	421232000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1025136000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	457163000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36703000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31122000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5336000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4407000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16296000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17584000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46282000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7813000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1801000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1275000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	82118000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	43322000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-45415000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12200000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	53000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	55000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-195000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	539000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-45663000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11716000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3795000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41868000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-11716000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11716000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.66
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63331702	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49792631	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	421232000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	38677000	USD
CY2021Q1	vcyt	Stock Issued And Sold During Period Value In Private Placement StockIssuedAndSoldDuringPeriodValueInPrivatePlacement	593821000	USD
CY2021Q1	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod	2806000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1159000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6774000	USD
CY2021Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee	3657000	USD
CY2021Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Non Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonEmployee	16000	USD
CY2021Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Espp AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP	182000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	974231000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	239455000	USD
CY2020Q1	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod	981000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1101000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2304000	USD
CY2020Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Employee AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployee	2551000	USD
CY2020Q1	vcyt	Adjustments To Additional Paid In Capital Share Based Compensation Espp AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationESPP	354000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-11716000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	230422000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-41868000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-11716000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2550000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1972000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	192000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3855000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2905000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3795000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021Q1	vcyt	Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty	53000	USD
CY2020Q1	vcyt	Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty DebtInstrumentEndOfTermPaymentInterestAmountAndPrepaymentPenalty	54000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2020Q1	us-gaap	Inventory Write Down InventoryWriteDown	1088000	USD
CY2021Q1	vcyt	Noncash Lease Expense NoncashLeaseExpense	258000	USD
CY2020Q1	vcyt	Noncash Lease Expense NoncashLeaseExpense	232000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-484000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-82000	USD
CY2020Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3748000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-238000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	376000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-132000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	818000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-135000	USD
CY2021Q1	vcyt	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-373000	USD
CY2020Q1	vcyt	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-331000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1931000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5450000	USD
CY2021Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue	238000	USD
CY2020Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue	-3650000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40561000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5301000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	574411000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1196000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	665000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-575607000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-665000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	593821000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6774000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2304000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3965000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2085000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	591012000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-219000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25156000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6185000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	349967000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	159920000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324811000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153735000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	357000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	113000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	324062000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	349364000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324811000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	349967000	USD
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Items subject to such estimates include: revenue recognition; write-down of supplies; the useful lives of property and equipment; the recoverability of long-lived assets; the incremental borrowing rate for leases; accounting for acquisitions; the estimation of the fair value of intangible assets and contingent consideration; variable interest entity assessment; impairment of equity investment, at cost; stock options; income tax uncertainties, including a valuation allowance for deferred tax assets; reserve on accounts receivable and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</span></div>
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8547297	shares
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	593800000	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	38700000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	749000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10496000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2725000	USD
CY2021Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	472113000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	474838000	USD
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4847191	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5716509	shares
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	164420000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12297000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	152123000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	70420000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59924000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y7M6D
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7300000	USD
CY2021Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7300000	USD
CY2021Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	171720000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12297000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	159423000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	70420000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10496000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	59924000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	11129000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14837000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6040000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14837000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14797000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14351000	USD
CY2021Q1	vcyt	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	82172000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	152123000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10214000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9201000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2504000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16254000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11705000	USD
CY2021Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3500000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.067
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2760000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3770000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3880000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3991000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4103000	USD
CY2021Q1	vcyt	Lessee Operating Lease Liability To Be Paid Due After Year Four LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour	1661000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	20165000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3251000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	16914000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2878000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14036000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	600000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9500287	shares
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2021Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	11339969	shares

Files In Submission

Name	View Source	Status
0001384101-21-000082-index-headers.html	Edgar Link	pending
0001384101-21-000082-index.html	Edgar Link	pending
0001384101-21-000082.txt	Edgar Link	pending
0001384101-21-000082-xbrl.zip	Edgar Link	pending
ex101deciphermergeragreeme.htm	Edgar Link	pending
exhibit31103-31x2021.htm	Edgar Link	pending
exhibit31203-31x2021.htm	Edgar Link	pending
exhibit32103-31x2021.htm	Edgar Link	pending
exhibit32203-31x2021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-20210331.htm	Edgar Link	pending
vcyt-20210331.xsd	Edgar Link	pending
vcyt-20210331_cal.xml	Edgar Link	unprocessable
vcyt-20210331_def.xml	Edgar Link	unprocessable
vcyt-20210331_htm.xml	Edgar Link	completed
vcyt-20210331_lab.xml	Edgar Link	unprocessable
vcyt-20210331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
VERACYTE, INC. Stock $vcyt

2021 Q1 Form 10-Q Financial Statement

#000138410121000082 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT VERACYTE, INC. Stock $vcyt

2021 Q1 Form 10-Q Financial Statement

#000138410121000082 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
VERACYTE, INC. Stock $vcyt